Skip to main content

Advertisement

Articles

Page 1 of 6

  1. Following publication of the original article [1], we have been notified of a few errors in the figures:

    Authors: Cristiane Mota Soares, Beatriz Nascimento, Luisa Arueira Chaves, Rondineli Mendes Silva, Maria Auxiliadora Oliveira and Vera Lucia Luiza

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:35

    Content type: Correction

    Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2019 12:33

  2. Glycated hemoglobin (HbA1c) is accepted as the most reliable marker for assessing chronic glycemia. The present study aimed to investigate glycemic control in cardiovascular outcome trials (CVOTs) performed by...

    Authors: Rumiko Shimazawa and Masayuki Ikeda

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:30

    Content type: Research

    Published on:

  3. Medicines wastage is one of the challenges of health supply chain management in developing countries including Ethiopia. However, there is lack of objective evidence on the detailed underlying causes of medici...

    Authors: Esayas Tadesse Gebremariam, Dawit Teshome Gebregeorgise and Teferi Gedif Fenta

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:29

    Content type: Research

    Published on:

  4. Infertility is a major challenge for couples globally. Due to low income levels and the high cost of other assisted reproductive techniques, pharmacotherapy remain the major first line treatment option for inf...

    Authors: Stephen Mensah Arhin, Kwesi Boadu Mensah, Evans Agbeno, Vitus Sambo Badii and Charles Ansah

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:28

    Content type: Research

    Published on:

  5. The Kuwaiti drug regulatory authority (DRA) lack a structured classification system for the assessment of imported herbal medicines (HMs), which leads to ambiguity in the registration process. This study aimed...

    Authors: Azhar H. Alostad, Douglas T. Steinke and Ellen I. Schafheutle

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:32

    Content type: Research

    Published on:

  6. Quality issues in pharmaceuticals are identified as a huge global and public health problem, especially with reference to low- and middle-income countries like Pakistan. The 2011 “Fake Drug Crisis” acted as a ...

    Authors: Huma Rasheed, Ludwig Hoellein, Khalid Saeed Bukhari and Ulrike Holzgrabe

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:23

    Content type: Review

    Published on:

  7. Two billion people worldwide, predominantly in low- and middle-income countries, cannot consistently access required essential medications, thus affecting their ability to attain optimal health outcomes. Acces...

    Authors: Marcia McLean, Jillian Clare Kohler and Danny Edwards

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:26

    Content type: Research

    Published on:

  8. To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.

    Authors: Alberto Frutos Pérez-Surio, Mercedes Gimeno-Gracia, Ma. Aránzazu Alcácera López, Ma. Asunción Sagredo Samanes, Ma. del Puerto Pardo Jario and Ma. del Tránsito Salvador Gómez

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:21

    Content type: Short report

    Published on:

  9. To describe changes in the private market for selected originators, branded generics (‘similares’), and generic products during the 10 years following passage of the Brazilian Generics Law.

    Authors: Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens and Dennis Ross-Degnan

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:18

    Content type: Research

    Published on:

  10. Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulati...

    Authors: Bethany Wilson, Sara S. McMillan and Amanda J. Wheeler

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:19

    Content type: Research

    Published on:

  11. The rational use of medicine improves patient’s quality of life. Excessive and inappropriate prescriptions result in severe consequences. The study of drug use patterns and prescription errors is necessary to ...

    Authors: Rajeev Shrestha and Srijana Prajapati

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:16

    Content type: Research

    Published on:

  12. As part of the initiatives to increase price transparency for consumers, pharmaceutical industry in Malaysia have been encouraged to declare the wholesale and recommended retail prices (RRP) of medicines to th...

    Authors: Nur Sufiza Ahmad, Ernieda Hatah and Mohd Makmor-Bakry

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:15

    Content type: Research

    Published on:

  13. Pharmaceutical pricing has only recently gained space in mainstream health science literature.

    Authors: Maria Angelica Borges dos Santos, Leticia Lucia dos Santos Dias, Cláudia Du Bocage Santos Pinto, Rondineli Mendes da Silva and Claudia Garcia Serpa Osorio-de-Castro

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:24

    Content type: Review

    Published on:

  14. Methemoglobinemia (MetHb) being a rare cause of cyanosis is generally not considered in its differential diagnosis. Methemoglobinemia is an abnormal Hb produced physiologically by auto-oxidation. If this proce...

    Authors: Najia Mahmood, Mutti Ullah Khan, Ihtisham U. L. Haq, Farhat Afshan Jelani and Aayesha Tariq

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:22

    Content type: Short report

    Published on:

  15. Questionnaires capture patient perspectives succinctly and at relatively low cost, making them a popular data collection tool for health researchers. However, questionnaire data can be affected by response err...

    Authors: Marissa Ayano Mes, Amy Hai Yan Chan, Vari Wileman, Caroline Brigitte Katzer, Melissa Goodbourn, Steven Towndrow, Stephanie Jane Caroline Taylor and Rob Horne

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:17

    Content type: Commentary

    Published on:

  16. Few low and middle-income countries (LMIC) have fully operational pharmacovigilance structures, systems and legal framework to collect and collate safety data and evaluate the risks and benefits by active and ...

    Authors: Onome T. Abiri and Wiltshire C. N. Johnson

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:13

    Content type: Research

    Published on:

  17. Improving access to medicines is a major healthcare challenge for low-income countries because the problem traverses health systems, society and multiple stakeholders. The Annapurna region of Nepal provides a ...

    Authors: Bhuvan K.C., Susan Heydon and Pauline Norris

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:11

    Content type: Research

    Published on:

  18. Countries all around the globe are working to establish robust pharmacovigilance systems. Whereas the majority of the developed countries have established well-organized pharmacovigilance systems, the developi...

    Authors: Rabia Hussain and Mohamed Azmi Hassali

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:14

    Content type: Commentary

    Published on:

  19. Existing literature does not provide enough information on evaluation of factors associated with pre-dialysis controlled hypertension among euvolemic hemodialysis (HD) patients. We conducted a study to evaluat...

    Authors: Amjad Khan, Amer Hayat Khan, Azreen Syazril Adnan, Syed Azhar Syed Sulaiman, Saima Mushtaq, Nafees Ahmad and Irfanullah Khan

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:10

    Content type: Research

    Published on:

  20. Universal Health Coverage (UHC) in Indonesia is planned to be fully implemented in 2019 through the National Health Insurance (NHI) launched in January 2014. However, limited financial resources cause health c...

    Authors: Endang Yuniarti, Yayi Suryo Prabandari, Erna Kristin and Sri Suryawati

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:7

    Content type: Research

    Published on:

  21. Expired or unused medicines are potentially toxic substances that should be managed effectively to avoid accumulation of potentially toxic pharmaceuticals in the environment. In Nigeria, there is currently lim...

    Authors: Iweh Michael, Brian Ogbonna, Nduka Sunday, Maureen Anetoh and Okonta Matthew

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:12

    Content type: Research

    Published on:

  22. In Kuwait, the government is planning to improve the specifications for purchase of medicine and to improve the tendering system intending to slow the growth of the expenditure for medicine and to improve the ...

    Authors: Ali Hadi Abdullah, Anke-Peggy Holtorf, Maryam Al-Hussaini, Jacinthe Lemay, Maryam Alowayesh and Zoltán Kaló

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:9

    Content type: Research

    Published on:

  23. Urinary tract infections (UTI) are commonly encountered in the emergency department (ED). ED culture follow up is an important tool to provide the appropriate therapy after the identification of the causative ...

    Authors: Abdulaziz Saleh Almulhim, Ali Aldayyen, Kateryna Yenina, Adam Chiappini and Tahir Mehmood Khan

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:8

    Content type: Research

    Published on:

  24. Proton pump inhibitors (PPIs) are used worldwide for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). Although considered to be widely safe, PPIs have been associated wit...

    Authors: Ejaz Cheema

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:6

    Content type: Review

    Published on:

  25. Pharmacy-based interventions are complex public health endeavors which include, but are not restricted to, the conventional medication supply role. In diabetes, such interventions may improve patients’ outcome...

    Authors: Suzete Costa, Maria Rute Horta, Rita Santos, Zilda Mendes, Isabel Jacinto, José Guerreiro, Maria Cary, Ana Miranda, Dennis K. Helling and Ana Paula Martins

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:5

    Content type: Review

    Published on:

  26. The availability of medicines in public health facilities in Tanzania is problematic. Medicines shortages are often caused by unavailability at Medical Stores Department, the national supplier for public healt...

    Authors: Karin Wiedenmayer, Romuald Mbwasi, William Mfuko, Ezekiel Mpuya, James Charles, Fiona Chilunda, Denis Mbepera and Ntuli Kapologwe

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:4

    Content type: Research

    Published on:

  27. Self-medication is a common practice globally and the resulting irrational drug use is raising concerns. Up-to-date there is no systematic study conducted on self medication practice among students or the gene...

    Authors: Zenawi Zeramariam Araia, Nahom Kiros Gebregziabher and Araia Berhane Mesfun

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:3

    Content type: Research

    Published on:

  28. The National Drug Authority (NDA) inspects and certifies private and public sector pharmacies in Uganda using an indicator-based inspection tool that measures adherence to good pharmacy practices (GPP). 67 mea...

    Authors: Brian Sekayombya, David Nahamya, Laura Garabedian, Morries Seru and Birna Trap

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:2

    Content type: Research

    Published on:

  29. To stimulate use of generic medicines a combination of supply and demand side mechanisms are employed in the Latvian reimbursement system. It is reported that patients have high out-of-pocket pharmaceutical sp...

    Authors: Ieva Salmane Kulikovska, Elita Poplavska, Marija Ceha and Signe Mezinska

    Citation: Journal of Pharmaceutical Policy and Practice 2019 12:1

    Content type: Research

    Published on:

  30. In Ghana, there is extensive over-the-counter dispensing of antibiotics, resulting in high levels of inappropriate use, and an increase in antibiotic resistance. Regulations prevent Licenced Chemical Sellers (...

    Authors: Samuel Afari-Asiedu, John Kinsman, Ellen Boamah-Kaali, Martha Ali Abdulai, Margaret Gyapong, Osman Sankoh, Marlies Hulscher, Kwaku Poku Asante and Heiman Wertheim

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:30

    Content type: Research

    Published on:

  31. High medicines prices increasingly pose challenges for universal access to treatments of communicable and non-communicable diseases. New essential medicines are often patent-protected which sustains high price...

    Authors: Ellen F. M. ‘t Hoen, Tapiwanashe Kujinga and Pascale Boulet

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:31

    Content type: Review

    Published on:

  32. In the United States (U.S.), large price increases for selected generic drugs have elicited public outrage. Recent legislative proposals aim to increase price transparency and identify outlier drug “price spik...

    Authors: Rena M. Conti, Kevin H. Nguyen and Meredith B. Rosenthal

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:29

    Content type: Research

    Published on:

  33. Pharmaceuticals are produced and consumed in increasing volume every year. Unfortunately, not all medications that go in to the hand of the consumers get consumed; large quantities remain unused or expire. The...

    Authors: Yohanes Ayele and Mulu Mamu

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:27

    Content type: Research

    Published on:

  34. Canadians have long been proud of their universal health insurance system, which publicly funds the cost of physician visits and hospitalizations at the point of care. Prescription drugs however, have been sub...

    Authors: Jaden Brandt, Brenna Shearer and Steven G. Morgan

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:28

    Content type: Review

    Published on:

  35. Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin Americ...

    Authors: Daniela Moye-Holz, Rene Soria Saucedo, Jitse P van Dijk, Sijmen A Reijneveld and Hans V Hogerzeil

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:25

    Content type: Research

    Published on:

  36. Rational prescribing remains an important component of rational drug use. The World Health Organization (WHO) standardized and validated core prescribing indicators for evaluating prescribing pattern of drugs....

    Authors: Tigist Gashaw, Mekonnen Sisay, Getnet Mengistu and Firehiwot Amare

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:26

    Content type: Research

    Published on:

  37. A strong pharmaceutical sector is a precondition for effective and efficient health care and financing systems, and thus for achieving the best possible health of a population. Supported by visionary, long-ter...

    Authors: Martin Oteba, Anita Katharina Wagner, Morries Seru, Martha Embrey and Birna Trap

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:23

    Content type: Commentary

    Published on:

  38. The United States-Peru Free Trade Agreement required changes in the Peruvian pharmaceutical legislation that resulted in the National Drug Policy (NDP) of 2009. This study evaluated the registration of brand a...

    Authors: Lita Araujo and Michael Montagne

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:24

    Content type: Research

    Published on:

  39. The emergency response phase to HIV epidemic in Nigeria and other countries saw to the deployment of donors’ resources with little consideration for country ownership (CO) and sustainability. The progress that...

    Authors: Ademola Joshua Itiola and Kenneth Anene Agu

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:21

    Content type: Research

    Published on:

  40. Pharmacists are critical for attaining the goal of universal health coverage and equitable access to essential health services, particularly in relation to access to medicines and medicines expertise. We descr...

    Authors: Aniekan Ekpenyong, Arit Udoh, Eneyi Kpokiri and Ian Bates

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:20

    Content type: Research

    Published on:

  41. In Australia, community pharmacists are increasingly being integrated into the healthcare system. A range of services in pharmacies are government-funded aiming to prevent chronic diseases and improve the qual...

    Authors: Vera H. Buss, Alison Shield, Sam Kosari and Mark Naunton

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:22

    Content type: Review

    Published on:

  42. Obesity is now widely regarded as a main contributor to poor health. Involvement of community pharmacists can be a valuable tool in obesity management. However, there is still a lack of data in Malaysia on the...

    Authors: Rohit Kumar Verma, Thomas Paraidathathu, Nur Akmar Taha and Wei Wen Chong

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:17

    Content type: Research

    Published on:

  43. The cost and potential harms of medicines and other health technologies are issues of concern for governments and third party payers of health care. Various means have been demonstrated to promote appropriate ...

    Authors: Lynn Maria Weekes, Suzanne Blogg, Sharene Jackson and Kerren Hosking

    Citation: Journal of Pharmaceutical Policy and Practice 2018 11:19

    Content type: Commentary

    Published on:

Annual Journal Metrics

Advertisement